Pain Drug Mobic Shows Increased Risk-FDA Scientist (Reuters


Reuters - A pain reliever called Mobic
has shown a higher risk of heart attacks in early data than
found with Merck & Co. Inc.'s now-withdrawn Vioxx, a veteran
U.S. Food and Drug Administration scientist told an FDA
advisory panel on Thursday.

Read more...